- 1D
- 3D
- 1W
- 1M
- 6M
- 1Y
- 3Y
- 5Y
- Is it time to catch this falling knife?
- A deal with Donald Trump is boosting this pharma giant
- Look at ‘forgotten’ pharma stocks to hedge the weight-loss war
- Hope for Novo Nordisk investors after Eli Lilly stumble
- Spotting undervalued shares, Savills & weight-loss drugs
- Want to find the best pharma stocks? Look at R&D
- Can Novo Nordisk turn it around?
More ▼
Key statistics
On Wednesday, Eli Lilly and Co (0Q1G:LSE) closed at 460.00, 0.00% below its 52-week high of 460.00, set on Sep 03, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | -- |
|---|---|
| High | 460.00 |
| Low | 460.00 |
| Bid | -- |
| Offer | -- |
| Previous close | 0.00 |
| Average volume | -- |
|---|---|
| Shares outstanding | 945.38m |
| Free float | 943.87m |
| P/E (TTM) | 44.47 |
| Market cap | 965.09bn USD |
| EPS (TTM) | 22.96 USD |
| Annual div (ADY) | 5.39 CHF |
|---|---|
| Annual div yield (ADY) | -- |
| Div ex-date | Nov 14 2025 |
| Div pay-date | Dec 10 2025 |
| Next div ex-date | Feb 13 2026 |
| Next div pay-date | Mar 10 2026 |
Data delayed at least 20 minutes, as of Sep 03 2025 15:29 BST.
More ▼
